Information  X 
Enter a valid email address

Hammerson PLC (HMSO)

  Print      Mail a friend       Annual reports

Thursday 05 March, 2020

Hammerson PLC

Director/PDMR Shareholding

RNS Number : 1831F
Hammerson PLC
05 March 2020
 

Hammerson plc (the Company)

Notification of Transaction of Director

5 March 2020

 

 

The Company was notified on 4 March 2020 that Adam Metz, a Non-Executive Director of the Company, has acquired 20,000 ordinary shares of 25 pence each (Shares) at a price of £1.99 per share.

 

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation. The notification of dealing form can be found below.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

 

Richard Crowle

Assistant Company Secretary

+44 (0) 20 7887 1000

 

 

Notification of dealing form

1

Details  of  the person discharging managerial responsibilities /  person closelyassociated

a)

Name

Adam Metz

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer

a)

Name

Hammerson plc

b)

LEI

213800G1C9KKVVDN1A60

4

Details ofthetransaction(s):sectiontoberepeatedfor(i)eachtypeofinstrument;

(ii) each type oftransaction;(iii)eachdate;and(iv)eachplacewheretransactionshave beenconducted

a)

Description of the financial instrument, type of instrument.

 

Identification code

Ordinary shares of 25 pence each

 

 

ISIN: GB0004065016

b)

Nature of the transaction

Purchase of ordinary shares of 25 pence

c)

Price(s) and volume(s)





Price(s)

Volume(s)


£1.99

20,000

d)

Aggregated information

-  Aggregated volume

-  Price






Aggregate Price

Aggregate Volume

Aggregate Total


£1.99

20,000

£39,800.00

e)

Date ofthe transaction

4 March 2020

f)

Place of the transaction

XLON

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEALDSEALEEFA

a d v e r t i s e m e n t